BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 15804701)

  • 21. Serum autoantibodies that bind citrullinated fibrinogen are frequently found in patients with rheumatoid arthritis.
    Hill JA; Al-Bishri J; Gladman DD; Cairns E; Bell DA
    J Rheumatol; 2006 Nov; 33(11):2115-9. PubMed ID: 16924693
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Opposing effects of HLA-DRB1*13 alleles on the risk of developing anti-citrullinated protein antibody-positive and anti-citrullinated protein antibody-negative rheumatoid arthritis.
    Lundström E; Källberg H; Smolnikova M; Ding B; Rönnelid J; Alfredsson L; Klareskog L; Padyukov L
    Arthritis Rheum; 2009 Apr; 60(4):924-30. PubMed ID: 19333936
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Diagnostic and prognostic significance of antibodies against citrullinated peptides].
    Schulze-Koops H; Manger B
    Dtsch Med Wochenschr; 2006 Feb; 131(6):269-71. PubMed ID: 16463231
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antibodies against mutated citrullinated vimentin are a better predictor of disease activity at 24 months in early rheumatoid arthritis than antibodies against cyclic citrullinated peptides.
    Innala L; Kokkonen H; Eriksson C; Jidell E; Berglin E; Dahlqvst SR
    J Rheumatol; 2008 Jun; 35(6):1002-8. PubMed ID: 18398946
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantitative heritability of anti-citrullinated protein antibody-positive and anti-citrullinated protein antibody-negative rheumatoid arthritis.
    van der Woude D; Houwing-Duistermaat JJ; Toes RE; Huizinga TW; Thomson W; Worthington J; van der Helm-van Mil AH; de Vries RR
    Arthritis Rheum; 2009 Apr; 60(4):916-23. PubMed ID: 19333951
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CD95-Mediated control of anti-citrullinated protein/peptides antibodies (ACPA)-producing plasma cells occurring in rheumatoid arthritis inflamed joints.
    Rodríguez-Bayona B; Pérez-Venegas JJ; Rodríguez C; Brieva JA
    Rheumatology (Oxford); 2007 Apr; 46(4):612-6. PubMed ID: 17132692
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of HLA-DR genes on the production of rheumatoid arthritis-specific autoantibodies to citrullinated fibrinogen.
    Auger I; Sebbag M; Vincent C; Balandraud N; Guis S; Nogueira L; Svensson B; Cantagrel A; Serre G; Roudier J
    Arthritis Rheum; 2005 Nov; 52(11):3424-32. PubMed ID: 16255019
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alterations of the synovial T cell repertoire in anti-citrullinated protein antibody-positive rheumatoid arthritis.
    Cantaert T; Brouard S; Thurlings RM; Pallier A; Salinas GF; Braud C; Klarenbeek PL; de Vries N; Zhang Y; Soulillou JP; Tak PP; Baeten D
    Arthritis Rheum; 2009 Jul; 60(7):1944-56. PubMed ID: 19565497
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk of progression from undifferentiated arthritis to rheumatoid arthritis: the effect of the PTPN22 1858T-allele in anti-citrullinated peptide antibody positive patients.
    Feitsma AL; Toes RE; Begovich AB; Chokkalingam AP; de Vries RR; Huizinga TW; van der Helm-van Mil AH
    Rheumatology (Oxford); 2007 Jul; 46(7):1092-5. PubMed ID: 17341507
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-cyclic citrullinated peptide testing for the diagnosis of rheumatoid arthritis and the quest for improved sensitivity and predictive value.
    Levesque MC; Zhou Z; Moreland LW
    Arthritis Rheum; 2009 Aug; 60(8):2211-5. PubMed ID: 19644881
    [No Abstract]   [Full Text] [Related]  

  • 31. IgG subclass distribution of the rheumatoid arthritis-specific autoantibodies to citrullinated fibrin.
    Chapuy-Regaud S; Nogueira L; Clavel C; Sebbag M; Vincent C; Serre G
    Clin Exp Immunol; 2005 Mar; 139(3):542-50. PubMed ID: 15730401
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Contribution of PTPN22 1858T, TNFRII 196R and HLA-shared epitope alleles with rheumatoid factor and anti-citrullinated protein antibodies to very early rheumatoid arthritis diagnosis.
    Goëb V; Dieudé P; Daveau R; Thomas-L'otellier M; Jouen F; Hau F; Boumier P; Tron F; Gilbert D; Fardellone P; Cornélis F; Le Loët X; Vittecoq O
    Rheumatology (Oxford); 2008 Aug; 47(8):1208-12. PubMed ID: 18535030
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Comparative characteristics of specific autoantibodies in rheumatoid arthritis].
    Lapin SV; Maslianskiĭ AL; Mazurov VI; Totolian AA
    Ter Arkh; 2005; 77(12):53-9. PubMed ID: 16514821
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glycan profiling of anti-citrullinated protein antibodies isolated from human serum and synovial fluid.
    Scherer HU; van der Woude D; Ioan-Facsinay A; el Bannoudi H; Trouw LA; Wang J; Häupl T; Burmester GR; Deelder AM; Huizinga TW; Wuhrer M; Toes RE
    Arthritis Rheum; 2010 Jun; 62(6):1620-9. PubMed ID: 20178128
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-citrullinated protein antibodies in rheumatoid arthritis: a functional role for mast cells and basophils?
    Suurmond J; Schuerwegh AJ; Toes RE
    Ann Rheum Dis; 2011 Mar; 70 Suppl 1():i55-8. PubMed ID: 21339220
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [New diagnostic and evaluative tests for rheumatoid arthritis].
    Hayashi N; Nishimura K; Morinobu A; Kumagai S
    Rinsho Byori; 2007 Apr; 55(4):388-96. PubMed ID: 17511271
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rheumatoid factor and anti-CCP autoantibodies in rheumatoid arthritis: a review.
    Lee AN; Beck CE; Hall M
    Clin Lab Sci; 2008; 21(1):15-8. PubMed ID: 18335856
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-CCP Antibody, a Marker for the Early Detection of Rheumatoid Arthritis.
    van Venrooij WJ; van Beers JJ; Pruijn GJ
    Ann N Y Acad Sci; 2008 Nov; 1143():268-85. PubMed ID: 19076355
    [TBL] [Abstract][Full Text] [Related]  

  • 39. IgG, IgA, IgM antibodies to a viral citrullinated peptide in patients affected by rheumatoid arthritis, chronic arthritides and connective tissue disorders.
    Anzilotti C; Riente L; Pratesi F; Chimenti D; Delle Sedie A; Bombardieri S; Migliorini P
    Rheumatology (Oxford); 2007 Oct; 46(10):1579-82. PubMed ID: 17717033
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Marked differences in fine specificity and isotype usage of the anti-citrullinated protein antibody in health and disease.
    Ioan-Facsinay A; Willemze A; Robinson DB; Peschken CA; Markland J; van der Woude D; Elias B; Ménard HA; Newkirk M; Fritzler MJ; Toes RE; Huizinga TW; El-Gabalawy HS
    Arthritis Rheum; 2008 Oct; 58(10):3000-8. PubMed ID: 18821680
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.